Effects of Capnometry Monitoring in Post Anesthesia Care Unit (CAPNOSSPI)

October 14, 2018 updated by: Karine Nouette-Gaulain, University Hospital, Bordeaux
There is few information about the best capnometry value in recovery room for intubated awakening patients. Furthermore, capnometry values could influence ventilation applied by nurses on these patients. The aim of this study is to observe the effects of capnometry monitoring on intubated awakening patients in recovery room.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

In France, there is actually no recommandation about capnography monitoring in recovery rooms. Nevertheless, some patients are still ventilated in post-anesthesia care units during awakening period. Alveolar hypoventilation could induce moderate hypercapnia, thereby stimulate central ventilatory command. However, this hypoventilation could delay the clearance of anesthetic gases. Capnometry monitoring could influence ventilation applied to these patients. Recovery rooms nurses would perform moderate hyperventilation in response to hign capnometry values. This method could enhance gases elimination, with faster spontaneous breathing recovery and extubation. Length of stay in recovery room could also be shortened. An objective surrogate of ventilation is maximal End Tidal CO2, if there is no alveolo-capillary gradient abnormality (Obesity, Chronic respiratory disease, Cyanogenic heart disease). Thus, this study will compare the percentage of patients who reached a maximum End Tidal CO2 greater than 45mmHg during awakening period in post-anesthesia care unit (PACU) in 2 groups :

  • first group ("non-blind group") with capnography monitoring see by the PACU nurses
  • second group ("blind group") with capnography monitoring but PACU nurses cannot see the values Other parameters like the time between ventilator's disconnection and the first ventilatory cycle in spontaneous ventilation, the time between ventilator's disconnection and tracheal extubation or laryngeal mask's withdrawal, the minimal SpO2 reached after tracheal extubation or laryngeal mask withdrawal or the length of stay in PACU are also recorded.

Study Type

Interventional

Enrollment (Actual)

53

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France, 33076
        • Centre Hospitalier Universitaire De Bordeaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Major patients with given written consent
  • General anesthesia, induction with Propofol infusion and Target-Controlled Infusion (TCI) remifentanil, relayed with inhaled sevoflurane and TCI remifentanil
  • Upper airway control with naso-orotracheal tube or laryngeal mask
  • Ventilated normotherm patients in PACU

Exclusion Criteria:

  • Minor or pregnant patients
  • Obesity with Body Mass Index > 40 kg/m²
  • Chronic respiratory disease with SpO2<90% in ambiant air
  • Cyanogenic heart disease
  • Patients under myorelaxant in PACU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CAPNO+
END TIDAL CO2(EtCO2) is monitoring and PACU nurses can see the values delivered by the capnography device
MONITORING OF CAPNOMETRY USING ETCO2 METHOD
No Intervention: CAPNO-
END TIDAL CO2(EtCO2) is monitoring but PACU nurses cannot see the values delivered by the capnography device

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
End Tidal CO2 up
Time Frame: through awakening period in PACU, an average of 30 minutes
Percentage of patients who reached a maximum End Tidal CO2 greater than 45mmHg during awakening period in post-anesthesia care unit (PACU)
through awakening period in PACU, an average of 30 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
End Tidal CO2 max 1
Time Frame: through awakening period in PACU, an average of 15 minutes
Maximum EtCO2 reached before the first ventilatory cycle in spontaneaous ventilation
through awakening period in PACU, an average of 15 minutes
End Tidal CO2 max 2
Time Frame: through awakening period in PACU, an average of 30 minutes
Maximum EtCO2 reached after the first ventilatory cycle in spontaneous ventilation
through awakening period in PACU, an average of 30 minutes
respiratory rate
Time Frame: through awakening period in PACU, an average of 15 minutes
Respiratory rate applied by PACU nurse before the first ventilatory cycle in spontaneous ventilation
through awakening period in PACU, an average of 15 minutes
spontaneous ventilation time
Time Frame: through awakening period in PACU, an average of 15 minutes
Time (in minutes) between ventilator's disconnection and the first ventilatory cycle in spontaneous ventilation
through awakening period in PACU, an average of 15 minutes
time for removal of airway device
Time Frame: through awakening period in PACU, an average of 30 minutes
Time (in minutes) between ventilator's disconnection and tracheal extubation or laryngeal mask's withdrawal
through awakening period in PACU, an average of 30 minutes
Spo2 min
Time Frame: through awakening period in PACU, an average of 2 hours
Minimal SpO2 after tracheal extubation or laryngeal mask withdrawal
through awakening period in PACU, an average of 2 hours
length of stay in PACU
Time Frame: through awakening period in PACU, an average of 2 hours
Length of stay in PACU in minutes
through awakening period in PACU, an average of 2 hours
time for oxygenotherapy removal
Time Frame: through awakening period in PACU, an average of 1 hour
Time (in minutes) between tracheal extubation or laryngeal mask withdrawal and oxygenotherapy weaning
through awakening period in PACU, an average of 1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 15, 2018

Primary Completion (Actual)

May 1, 2018

Study Completion (Actual)

June 1, 2018

Study Registration Dates

First Submitted

December 4, 2017

First Submitted That Met QC Criteria

December 11, 2017

First Posted (Actual)

December 12, 2017

Study Record Updates

Last Update Posted (Actual)

October 16, 2018

Last Update Submitted That Met QC Criteria

October 14, 2018

Last Verified

October 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX2017/18

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Capnography

Clinical Trials on CAPNOGRAPHY

Subscribe